TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2025
Back to search
Official data from USPTO
GOGLICO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/11/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
10/10/2023
Registration date
12/24/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
12/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Porto, PT
Examiner
KIDWELL WALKER,JACLYN NOEMI
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
GOGLICO, UNIPESSOAL LDA
Representatives
Elizabeth Lee D'Amore Lucas & Mercanti, LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Glucose for use as an additive to foods for medical purposes; nutritional supplements for medical purposes; capsules sold empty for medicines being pharmaceuticals and nutritional supplements; sachets sold empty for pharmaceutical purposes in the nature of medicines and nutritional supplements; gelatin for medical purposes; medicinal healthcare preparationspharmaceutical preparations for the treatment of diabetespharmaceutical preparations for the treatment of asthmapharmaceutical preparations for the treatment of convulsionspharmaceutical preparations for the treatment of myocardial infarctionpharmaceutical preparations for the treatment of Cerebral Vascular Accident (CVA)pharmaceutical preparations for the treatment of high or low blood pressureanalgesicsnutritional supplements; chemical preparations for medical purposespharmaceutical preparations for the treatment of diabetespharmaceutical preparations for the treatment of asthmapharmaceutical preparations for the treatment of convulsionspharmaceutical preparations for the treatment of myocardial infarctionpharmaceutical preparations for the treatment of Cerebral Vascular Accident (CVA)pharmaceutical preparations for the treatment of panic attacks; sugar for medical purposes; medicinal drinks; pharmaceutical compositionsantitussive-cold preparationsantiviralsanticonvulsant drugsglucose gelnitroglycerinaspirinbronchodilatorstriptansbenzodiazepines; pharmaceutical sweets being medicated sweets; candy for medical purposes; medicated candy; medicated lozenges; anti-diabetic pharmaceuticals; autonomic drugs for medical purposes used to treat conditions of the parasympathetic and sympathetic nervous systems; glucose for medical purposes; gum for medical purposes; antidiabetic preparations; cardiovascular preparations being pharmaceuticals used to treat cardiovascular disease; glucose preparations for medical purposes; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for human use for the treatment of hypoglycemiaasthmaacute painangina and myocardial infarctionconvulsionspanic attackshypotension and hypertension; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating hypertension; ; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; cardiovascular pharmaceuticals used to treat cardiovascular diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; chemical pharmaceutical preparations for the treatment of hypoglycemiaasthmaacute painangina and myocardial infarctionconvulsionspanic attackshypotension and hypertension
Class 10
Wrist braces for medical use; applicators for medications; applicators for pharmaceutical preparations; braces for application to the human body for medical use; bracelets for medical purposes
Publications
History of USPTO decisions and trademark events.
29 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2024
PUBO
PUBLISHED FOR OPPOSITION
10/22/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/17/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/17/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/17/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/29/2024
GNRT
NON-FINAL ACTION E-MAILED
08/29/2024
CNRT
NON-FINAL ACTION WRITTEN
08/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/28/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/04/2024
GNRT
NON-FINAL ACTION E-MAILED
06/04/2024
CNRT
NON-FINAL ACTION WRITTEN
06/04/2024
DOCK
ASSIGNED TO EXAMINER
05/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2023
NWAP
NEW APPLICATION ENTERED
10/13/2023
Continuous trademark protection
Get notified about every new filing that threatens GOGLICO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.